During 2018, the Company acquired additional real property and determined that a previously insignificant operating segment Real Estate and Construction is now significant and is a reportable segment requiring disclosure in accordance with ASC 280. Prior period information below has been revised to conform to current period presentation. We are now organized into three reportable segments: Herbs and Produce Products Includes herbs and leafy greens that are grown using classic Dutch hydroponic farming methods. Cannabis Dispensary, Cultivation and Production Includes cannabis-focused retail, cultivation and production. Real Estateand Construction Includes building ownership where cannabis dispensary and/or cultivation operations are currently in development. Our segment net revenue and contributions to consolidated net revenue for each of the last two fiscal years were as follows: (in thousands) Total Revenue % of Total Revenue Year Ended Decemeber 31, Year Ended December 31, 2019 2018 2019 2018 Herbs and Produce Products $ 5,284 $ 4,476 18.8 % 15.9 % Cannabis Dispensary, Cultivation and Production 22,416 14,872 79.9 % 83.9 % Real Estate - - -% -% Corporate and Other 350 817 1.2 % 0.2 % Total $ 28,050 20,165 100.0 % 100.0 % See Note 2 Summary of Significant Accounting Policies to our consolidated financial statements for financial information about our segments. See also Item 1A. Risk Factors below for a discussion of certain risks associated with our operations. Herbs and Produce Products Either independently or in conjunction with third parties, we are a retail seller of locally grown hydroponic herbs and produce, which are distributed through major grocery stores throughout the East, West and Midwest regions of the U.S. Cannabis Dispensary, Cultivation and Production Either independently or in conjunction with third parties, we operate medical marijuana retail and adult use dispensaries and a medical marijuana and adult use cultivation in Nevada. In addition, we operate retail medical and adult use marijuana dispensary facilities in California, and have medical marijuana and adult use cultivation and production facilities in California. All of our retail dispensaries in California and Nevada offer a broad selection of medical and adult use cannabis products including flowers, concentrates and edibles. We also produce and sell a line of medical and adult use cannabis flowers, as well as a line of medical and adult use cannabis-extracted products, which include concentrates, cartridges, and wax products. Real Estate We own real property in Nevada. Additionally, we own properties in California that are in various stages of construction for medical marijuana and adult use cultivation and production facilities and dispensaries. Summarized financial information concerning the Company s reportable segments is shown in the following tables. Total asset amounts at December 31, 2019 and 2018 excludes intercompany receivable balances eliminated in consolidation. (in thousands) For the Year Ended December 31, 2019 Herbs and Produce Products Cannabis Dispensary, Cultivation and Production Real Estate Eliminations and Other Total Total revenues $ 5,284 $ 22,416 $ - $ 350 $ 28,050 Cost of goods sold 3,955 $ 9,114 $ - $ 327 13,396 Gross profit 1,329 13,302 - 23 14,654 Depreciation &amp; amortization 540 $ 6,458 $ - $ 215 7,213 Stock-based compensation - $ - $ - $ 4,918 4,918 Selling, general and administrative expenses (all other) 4,783 $ 11,174 $ 334 $ 16,899 33,190 Loss from operations (3,994 ) (4,330 ) (334 ) (22,009 ) (30,667 ) Other income / (expense): Interest income/(expense) - $ (16 ) $ (1,007 ) $ (8,274 ) (9,297 ) Other income / (loss) 34 $ (7,794 ) $ - $ (716 ) (8,476 ) Total Other Income (Expense) 34 (7,810 ) (1,007 ) (8,990 ) (17,773 ) Loss Before Provision for Income Taxes $ (3,960 ) $ (12,140 ) $ (1,341 ) $ (30,999 ) $ (48,440 ) Total Assets at December 31, 2019 $ (8,201 ) $ 56,777 $ (2,545 ) $ 73,218 $ 119,249 For the Year Ended December 31, 2018 Herbs and Produce Cannabis Dispensary, Cultivation and Production Real Estate Eliminations and Other Total Total Revenues $ 4,476 $ 14,872 $ - $ 817 $ 20,165 Cost of Goods Sold 4,233 7,241 - 1,684 13,158 Gross Profit 243 7,631 - (867 ) 7,007 Depreciation &amp; amortization 523 3,951 - 232 4,706 Stock-based compensation - - - 3,136 3,136 Selling, General and Administrative Expenses 3,682 10,192 973 15,221 30,068 Loss from Operations (3,962 ) (6,512 ) (973 ) (19,456 ) (30,903 ) Other income / (expense): Interest income/(expense) - - (687 ) (10,283 ) (10,970 ) Other income / (loss) (77 ) - (107 ) 3,075 2,891 Total Other Income (Expense) (77 ) - (794 ) (7,208 ) (8,079 ) Loss Before Provision for Income Taxes $ (4,039 ) $ (6,512 ) $ (1,767 ) $ (26,664 ) $ (38,982 ) Total Assets at December 31, 2018 $ (6,871 ) $ 40,734 $ 4,248 $ 81,978 $ 120,088